A detailed history of Vital Stone Financial, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Vital Stone Financial, LLC holds 15,582 shares of TXG stock, worth $222,978. This represents 0.25% of its overall portfolio holdings.

Number of Shares
15,582
Previous 36 43183.33%
Holding current value
$222,978
Previous $0 Infinity%
% of portfolio
0.25%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$15.71 - $23.49 $244,227 - $365,175
15,546 Added 43183.33%
15,582 $351,000
Q2 2024

Aug 07, 2024

SELL
$19.45 - $37.37 $564 - $1,083
-29 Reduced 44.62%
36 $0
Q1 2024

May 06, 2024

SELL
$36.08 - $54.3 $127,542 - $191,950
-3,535 Reduced 98.19%
65 $2,000
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $123,346 - $206,834
3,594 Added 59900.0%
3,600 $201,000
Q4 2022

Jan 30, 2023

BUY
$24.4 - $41.3 $146 - $247
6 New
6 $0

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.36B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Vital Stone Financial, LLC Portfolio

Follow Vital Stone Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vital Stone Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vital Stone Financial, LLC with notifications on news.